Headquarters: São Paulo, Sao Paulo, Brazil
Total Funding: 2100000
Founded Date: 2012-02-01
Investors Number: 3
Estimated Revenue: $1M to $10M
Last Funding Date: 2015-04-06
Industry: Atrificial Vectors and Immune Cells
Last Funding Type: Venture - Series Unknown